Literature DB >> 27526080

Alterations in Outer Membrane Permeability Favor Drug-Resistant Phenotype of Klebsiella pneumoniae.

Lucia Pulzova1, Lucie Navratilova2,3, Lubos Comor1.   

Abstract

The increasing number of infections caused by multidrug-resistant and pandrug-resistant bacteria represents a serious worlwide problem. Drug resistance limits available antimicrobials and can lead to suboptimal treatment of bacterial infections. It can be predicted that resistance to more antimicrobial drugs will be acquired by even more bacteria in the future. Among the distinct resistance strategies, preventing drug entrance to intracellular compartment through modification of membrane permeability (bacterial influx) and active export of compounds to the external environment (bacterial efflux) are of particular importance as they limit the interaction of the drug with its intracellular targets and, consequently, its deleterious effects on the cell. Several current studies have extended our understanding of drug resistance mechanisms associated with altered membrane permeability in gram-negative bacteria. In this study, we propose a summary of resistance mechanisms associated with transport of drugs across bacterial cell envelope exploited by Klebsiella pneumoniae, one of the most common nosocomial infection-causing pathogens. The better understanding of molecular bases of drug transport in/out of the single cell may have consequence for success in antimicrobial therapy of infection caused by drug-resistant Klebsiella.

Entities:  

Keywords:  Klebsiella; drug resistance; efflux pumps; influx; porin

Mesh:

Substances:

Year:  2016        PMID: 27526080     DOI: 10.1089/mdr.2016.0017

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  10 in total

Review 1.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

2.  High Osmotic Stress Increases OmpK36 Expression through the Regulation of KbvR to Decrease the Antimicrobial Resistance of Klebsiella pneumoniae.

Authors:  Meng Wang; Yujiao Tian; Li Xu; Fusheng Zhang; Huigai Lu; Moran Li; Bei Li
Journal:  Microbiol Spectr       Date:  2022-06-06

3.  Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime/avibactam resistance in Klebsiella pneumoniae.

Authors:  Lingxiao Sun; Haibo Li; Qi Wang; Yingmei Liu; Bin Cao
Journal:  BMC Microbiol       Date:  2021-08-19       Impact factor: 3.605

4.  Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.

Authors:  Marta Hernández-García; Juan Antonio Castillo-Polo; Desirèe Gijón Cordero; Blanca Pérez-Viso; María García-Castillo; Javier Saez de la Fuente; María Isabel Morosini; Rafael Cantón; Patricia Ruiz-Garbajosa
Journal:  J Clin Microbiol       Date:  2022-03-16       Impact factor: 11.677

Review 5.  Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens.

Authors:  Anjali Y Bhagirath; Yanqi Li; Rakesh Patidar; Katherine Yerex; Xiaoxue Ma; Ayush Kumar; Kangmin Duan
Journal:  Int J Mol Sci       Date:  2019-04-10       Impact factor: 5.923

6.  OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo.

Authors:  Joshua L C Wong; Maria Romano; Louise E Kerry; Hok-Sau Kwong; Wen-Wen Low; Stephen J Brett; Abigail Clements; Konstantinos Beis; Gad Frankel
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

7.  Analysis of diverse β-lactamases presenting high-level resistance in association with OmpK35 and OmpK36 porins in ESBL-producing Klebsiella pneumoniae.

Authors:  Hasan Ejaz
Journal:  Saudi J Biol Sci       Date:  2022-02-25       Impact factor: 4.052

8.  Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.

Authors:  Andrea Rocker; Jake A Lacey; Matthew J Belousoff; Jonathan J Wilksch; Richard A Strugnell; Mark R Davies; Trevor Lithgow
Journal:  mBio       Date:  2020-04-14       Impact factor: 7.867

Review 9.  Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis; Achilleas Gikas
Journal:  Infection       Date:  2020-09-01       Impact factor: 3.553

10.  Phylogeography and resistome of pneumococcal meningitis in West Africa before and after vaccine introduction.

Authors:  Madikay Senghore; Peggy-Estelle Tientcheu; Archibald Kwame Worwui; Sheikh Jarju; Catherine Okoi; Sambou M S Suso; Ebenezer Foster-Nyarko; Chinelo Ebruke; Mohamadou Sonko; Mamdou Hama Kourna; Joseph Agossou; Enyonam Tsolenyanu; Lorna Awo Renner; Daniel Ansong; Bakary Sanneh; Catherine Boni Cisse; Angeline Boula; Berthe Miwanda; Stephanie W Lo; Rebecca A Gladstone; Stephanie Schwartz; Paulina Hawkins; Lesley McGee; Keith P Klugman; Robert F Breiman; Stephen D Bentley; Jason M Mwenda; Brenda Anna Kwambana-Adams; Martin Antonio
Journal:  Microb Genom       Date:  2021-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.